Skip to main content
. 2024 Jan 16;240(3):487–493. doi: 10.1159/000536172

Table 2.

Comparison of DFSP with and without fibrosarcomatous areas

Total Fibrosarcomatous Rest of cases
Patients, n (%) 148 16 (10.81) 132 (89.19)
Ethnicity, n (%)
 Caucasian 139 (93.92) 14 (87.5) 125 (94.70)
 African 6 (4.05) 1 (6.25) 5 (3.79)
 South American 3 (2.03) 1 (6.25) 2 (1.51)
Sex, n (%)
 Female 74 (50) 10 (62.5) 64 (48.48)
 Male 74 (50) 6 (37.5) 68 (51.52)
Age at diagnosis, mean (SD), years 46.28 (14.431) 54.44 (20.970) 45.29 (13.199)
Evolution at diagnosis, median (IQR), months 36 (72) 42 (99) 36 (63)
Diameter, median (IQR), cm 3 (3) 6.4 (7.5) 3 (2.2) p = 0.003
Site (148 tumours), n (%)
 Head and neck 15 (10.14) 2 (12.50) 13 (9.85)
 Chest 31 (20.95) 4 (25.00) 27 (20.45)
 Abdomen 16 (10.81) 1 (6.25) 15 (11.36)
 Upper back 43 (29.05) 2 (12.5) 41 (31.06)
 Lower back 10 (6.76) 1 (6.25) 9 (6.82)
 Upper extremities 10 (6.76) 2 (12.50) 8 (6.06)
 Lower extremities 23 (15.54) 4 (25.00) 19 (14.39)
Distal extremities (forearm 1, foot 5), n (%) 6 (4.05) 1 (6.25) 5 (3.79)
Previous scar, n (%) 6 (4.05) 0 (0) 6 (4.55)
Pigmented (Bednar tumour), n (%) 3 (2.03) 0 (0) 3 (2.27)
Recurrence, n (%) 17 (11.49) 8 (50) 9 (6.82) p < 0.001